Skip to content

Incyte Diagnostics Selects New CEO

January 20, 2015
Don Larsen, CEO

Don Larsen, CEO

Incyte Diagnostics has announced that Don Larsen has been selected as the organization’s first chief executive officer (CEO). He assumed permanent CEO duties on January 1, 2015 after acting as interim CEO since June, 2014.

“Mr. Larsen has a background in finance and healthcare and he has been a successful hospital and laboratory CEO. He has proven he can work well throughout the company and with the physicians. He will help shape the mission and vision of the company as we move into Healthcare Reform. We are delighted that he has accepted the position,” said David C. Hoak, M.D., president of Incyte Diagnostics.

“I am honored and very excited to have the opportunity to lead such an exceptional organization of dedicated and knowledgeable healthcare professionals,” said Larsen, CEO. “It is very impressive to see an organization with over 40 pathologists and nearly 200 employees so committed to the quality of care we offer patients and the service we provide to hospitals, clinics and physicians. I am committed to enhancing these efforts. Incyte is truly an outstanding organization with a bright future.”

Don has enjoyed 30 years in the health care industry, including being a CFO and CEO at several Hospital Corporation of America/Columbia facilities and in regional positions for the same organization. Additionally, Don held several positions with AmeriPath, a national anatomic pathology laboratory company, including being the CEO of two anatomic pathology labs and a regional executive director.

Don has experience in a broad array of additional business ventures where he has served as a CEO, partner or consultant.


Comments are closed.